Nomad Power Solutions, Inc. SEC filings NMAD

Nomad Power Solutions, Inc. has 528 filings in SEC EDGAR's recent list, going back to Aug 3, 2005. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 31, 2026 Dec 31, 2025
10-K Annual report Mar 24, 2025 Dec 31, 2024
10-K Annual report Mar 19, 2024 Dec 31, 2023
10-K Annual report Mar 29, 2023 Dec 31, 2022
10-K Annual report Mar 21, 2022 Dec 31, 2021
10-K Annual report Mar 26, 2021 Dec 31, 2020
10-K Annual report Mar 25, 2020 Dec 31, 2019
10-K Annual report Mar 25, 2019 Dec 31, 2018
10-K Annual report Mar 23, 2018 Dec 31, 2017
10-K Annual report Mar 29, 2017 Dec 31, 2016
10-K Annual report Mar 28, 2016 Dec 31, 2015
10-K Annual report Mar 27, 2015 Dec 31, 2014
10-K Annual report Mar 21, 2014 Dec 31, 2013
10-K Annual report Mar 15, 2013 Dec 31, 2012
10-K Annual report Mar 29, 2012 Dec 31, 2011
10-K Annual report Mar 28, 2011 Dec 31, 2010
10-K Annual report Mar 29, 2010 Dec 31, 2009
10-K Annual report Mar 31, 2009 Dec 31, 2008

Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NMAD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boca Raton, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1335105
Former names
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (until Jul 2, 2026); SRKP 7 INC (until Dec 1, 2006)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.